Early-Phase Clinical Trials in Argentina

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Early-Phase Clinical Trials in Argentina

Early-Phase Clinical Trials in Argentina – Clinical Research in South America

In the dynamic landscape of medical research, early-phase clinical trials serve as the crucible of innovation, spearheading the discovery of transformative treatments and therapies. Among the nations at the forefront of this journey, Argentina has emerged as a prominent contender, offering a blend of diverse patient populations, cutting-edge medical infrastructure, and a supportive regulatory framework.

This blog delves into the realm of early-phase clinical trials in Argentina, unraveling the reasons behind its prominence, the regulatory landscape, advantages, challenges, and the global ramifications for medical progress.

The Magnetism of Argentina for Early-Phase Clinical Trials

Argentina’s allure for early-phase clinical trials lies in a fusion of factors that position it as a prime hub for groundbreaking research. Its population, characterized by genetic diversity and varied ethnicities, provides researchers with a distinctive avenue to assess the efficacy of treatments across a spectrum of profiles. This genetic diversity significantly bolsters the applicability of trial findings to international patient populations.

Furthermore, the cost-effectiveness of conducting clinical trials in Argentina acts as a powerful magnet for researchers and pharmaceutical companies alike. The relatively lower costs associated with trials, spanning patient recruitment, site maintenance, and operational expenses, render Argentina an economically viable choice for research endeavors.

This cost-efficiency, however, does not compromise the integrity of research or the ethical standards upheld throughout the trials.

Regulatory Framework and Ethical Considerations

Argentina boasts a robust regulatory framework that safeguards patient well-being, upholds data integrity, and ensures adherence to ethical guidelines in clinical trials. The National Administration of Drugs, Food and Medical Devices (ANMAT) serves as the regulatory authority responsible for overseeing clinical trials and ensuring compliance with national and international standards.

Ethical considerations hold paramount importance, with clinical trial protocols undergoing rigorous evaluation by ethics committees before commencement.

Advantages and Contributions

Conducting early-phase clinical trials in Argentina yields advantages that transcend financial considerations. Through participation in these trials, Argentine patients gain access to cutting-edge treatments that may otherwise remain inaccessible. This nurtures a sense of community engagement and bolsters the dissemination of medical knowledge among healthcare professionals.

Furthermore, the collaboration between international research entities and local institutions fortifies Argentina’s healthcare infrastructure. This collaboration facilitates the exchange of knowledge, supports the development of local researchers, and augments the nation’s capacity for advanced clinical research. The presence of such trials stimulates the growth of specialized clinical research centers, attracting expertise and investments to the healthcare sector.

Early-Phase Clinical Trials in Argentina

Early-Phase Clinical Trials in Argentina

Early-Phase Clinical Trials in Argentina

Challenges and Mitigation

While Argentina presents a conducive environment for early-phase clinical trials, challenges are not absent. One notable challenge involves maintaining a consistent supply of qualified investigators and site personnel capable of conducting trials in accordance with international standards. Addressing this challenge requires investments in education and training programs to elevate the skills of healthcare professionals engaged in clinical research.

Patient recruitment and retention pose additional challenges. Enrolling a sufficient number of participants within specific criteria can prove daunting. Transparent patient communication and engagement strategies, complemented by culturally sensitive approaches, are imperative for overcoming these recruitment hurdles.

Global Implications

Argentina’s involvement in early-phase clinical trials carries implications that reverberate globally. The insights gleaned from trials conducted within the nation hold far-reaching consequences, especially for diseases prevalent in diverse populations. These trials contribute to the advancement of personalized medicine, tailoring treatments to individual genetic profiles, thereby enhancing efficacy and reducing adverse effects.

Furthermore, Argentina’s role in early-phase clinical trials accelerates medical innovation on an international scale. As new treatments emerge, they seamlessly integrate into global healthcare practices, benefiting patients across the world. Argentina’s collaborative approach to clinical research sets a precedent for international partnerships and knowledge exchange that transcend geographical boundaries.


Early-phase clinical trials in Argentina encapsulate the fusion of medical progress, patient well-being, and international collaboration. The nation’s diverse populace, robust regulatory environment, and cost-effectiveness position it as a frontrunner in this pivotal realm of medical research. As Argentina continues to shape the trajectory of healthcare innovation, the world observes with anticipation, recognizing its pivotal role in advancing global health and the boundaries of medical science.

Early-Phase Clinical Trials in Argentina

Source: World Courier

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Early-Phase Clinical Trials in Argentina

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Early-Phase Clinical Trials in Argentina

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Early-Phase Clinical Trials in Argentina

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Early-Phase Clinical Trials in Argentina

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Early-Phase Clinical Trials in Argentina

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Early-Phase Clinical Trials in Argentina

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Early-Phase Clinical Trials in Argentina

The Cohortias Team

Early-Phase Clinical Trials in Argentina

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Early-Phase Clinical Trials in Argentina

Network & Partnerships